摘要:
Secreted luciferases which are different from those known heretofore have been desired. The present invention provides a luciferase mutant comprising an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2.
摘要:
Secreted luciferases which are different from those known heretofore have been desired. The present invention provides a luciferase mutant comprising an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2.
摘要翻译:已经期望与之前已知的分泌的萤光素酶不同。 本发明提供了包含氨基酸序列的荧光素酶突变体,其中在SEQ ID NO:2的氨基酸序列中缺失选自1至4位的氨基酸的至少一个氨基酸。
摘要:
There has been a demand for a codon-optimized gene for the mutated catalytic domain of Oplophorus luciferase, which is capable of efficiently expressing a protein both in a cultured animal cell and Escherichia coli. There has also been a demand for a substrate coelenterazine analogue showing a higher activity than that of native 19 kDa protein. The invention provides a polynucleotide comprising a polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2. According to the invention, bis-coelenterazine is used as a substrate coelenterazine analogue suitable for the photoprotein encoded by the polynucleotide comprising the polynucleotide consisting of the nucleotide sequence of SEQ ID NO: 2.
摘要翻译:已经需要针对Oplophorus萤光素酶的突变催化结构域的密码子优化的基因,其能够在培养的动物细胞和大肠杆菌中有效地表达蛋白质。 还需要一种显示出比天然的19kDa蛋白质更高的活性的底物coelenterazine类似物。 本发明提供了包含由SEQ ID NO:2的核苷酸序列组成的多核苷酸的多核苷酸。根据本发明,双 - 肠里注胺用作底物coelenterazine类似物,其适用于由包含由核苷酸组成的多核苷酸的多核苷酸编码的光蛋白 SEQ ID NO:2的序列。
摘要:
A novel luciferase that is distinct from conventional luciferase has been desired. A luciferase mutant comprising an amino acid sequence in which glutamic acid at position 4, arginine at position 11, leucine at position 18 and valine at position 27 are substituted with other amino acids, in the amino acid sequence of SEQ ID NO: 2.
摘要翻译:已经需要与常规荧光素酶不同的新型荧光素酶。 在SEQ ID NO:2的氨基酸序列中,包含其中4位谷氨酸,11位精氨酸,18位亮氨酸和27位缬氨酸被氨基酸序列取代的氨基酸序列的荧光素酶突变体。
摘要:
A novel luciferase that is distinct from conventional luciferase has been desired.A luciferase mutant comprising an amino acid sequence in which tyrosine at position of 138 is substituted with another amino acid and at least 3 amino acids selected from the group consisting of isoleucine at position of 90, proline at position of 115, glutamine at position of 124 and asparagine at position of 166 are substituted with other amino acids, in the amino acid sequence of SEQ ID NO: 2.
摘要翻译:已经需要与常规荧光素酶不同的新型荧光素酶。 一种荧光素酶突变体,其包含其中138位的酪氨酸被另一个氨基酸取代的氨基酸序列,以及选自位于90的异亮氨酸,115位的脯氨酸和124位的谷氨酰胺的至少3个氨基酸 在166位的天冬酰胺被SEQ ID NO:2的氨基酸序列中的其它氨基酸取代。
摘要:
Luciferases which are different from those known heretofore have been desired. A luciferase mutant comprising an amino acid sequence in which at least one amino acid selected from the group consisting of valine at the position of 44, alanine at the position of 54 and tyrosine at the position of 138 is substituted with other amino acid(s) in the amino acid sequence of SEQ ID NO: 2.
摘要翻译:与以前已知的荧光素酶不同的荧光素酶是期望的。 一种荧光素酶突变体,其包含氨基酸序列,其中至少一个选自44位的缬氨酸,54位的丙氨酸和138位的酪氨酸的氨基酸被其它氨基酸取代, 在SEQ ID NO:2的氨基酸序列中。
摘要:
A target protein is prepared as soluble protein using a recombinant protein expression system. An expression vector is used that includes (1) an expression-inducible promoter sequence; (2) a first coding sequence including a polynucleotide coding for a polypeptide that is represented by the formula (Z)n; and (3) a second coding sequence that includes a polynucleotide that codes for a target protein. A method of producing the target protein is also used that includes expressing protein using this expression vector.
摘要:
A novel luciferase that is distinct from conventional luciferase has been desired. A luciferase mutant comprising an amino acid sequence in which glutamic acid at position 4, arginine at position 11, leucine at position 18 and valine at position 27 are substituted with other amino acids, in the amino acid sequence of SEQ ID NO: 2.
摘要:
The screening method of the present invention is useful for screening drugs such as insulin secretagogues having an insulin secretagogue activity with minimized side effects (hypoglycemia induction, etc.). The transformant in which a polynucleotide encoding the fusion protein used for the screening method is introduced, the screening kit comprising the transformant, etc. are also useful for screening excellent drugs.
摘要:
Secreted luciferases which are different from those known heretofore have been desired. The present invention provides a luciferase mutant comprising an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2.